|
|
|
|
|
by refurb
4772 days ago
|
|
I'd have to disagree with the "modest gains" in life expectancy for cancer patients. We have made some incredible progress in the last few years. The best example is chronic myelogenous leukemia. Before Gleevec was launched, the 5 year survival rate was 30%. Now? It's into the mid-90s and basically the same as the general population. And Gleevec isn't the only drug that has changed the natural progression of cancer. There are drugs in the pipeline that will basically "cure" other types of cancer as well. |
|